Back to Results

Syra Health Corp (SYRA)

Syra Health Corp. is a healthcare services company listed on OTC Markets as common stock under the symbol SYRA. Based in Carmel, Indiana, the company was incorporated in 2020 and operates in the United States. Its activities span behavioral and mental health, population health, digital health, health education and training, and workforce development and staffing for healthcare providers. Syra Health also develops digital tools such as Syrenity, a mental health application, SyraBot, a care-journey chatbot, and CarePlus, an electronic medical records solution for smaller healthcare organizations. In addition, it provides analytics services, epidemiology and health equity analytics, medical communications, patient education, and healthcare training, and recruits nurses and allied health professionals for fixed-term placements. Its customers include mental health hospitals, government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-SYRA
$0.70
-7.6% Downside
Fair
—
—
—
Great
—
—
—
0.0%
August 6, 2026
-72.0x
5.6x
1.7x
13.178 M
10.329 M
0.6%
39.3%
4.1
—
-412.8%
Send a message
Valuation • Fair Value

Syra Health Corp (OTC-SYRA) Fair Value by Valuation Model

Compare the primary fair value estimate for Syra Health Corp (OTC-SYRA) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$0.70

Estimated downside of 7.6% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.75

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$0.49

Earnings power value estimate.

Comps Fair Value

$0.73

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Syra Health Corp (OTC-SYRA) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Syra Health Corp (OTC-SYRA)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

7.642 M

Current operating scale indicator.

Revenue Forecast

7.226 M

Forward revenue estimate.

EBITDA

-221.522 K

Current operating profitability reference.

EBITDA Forecast

Not available

Data is currently unavailable.

How to read profitability and growth

This section helps investors review Syra Health Corp (OTC-SYRA) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Syra Health Corp (OTC-SYRA)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Great

Positive financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-4.04

No elevated caution signal from this screen.

Altman Z-Score

4.1

Relatively strong balance-sheet zone.

FCF / Net Income

-412.8%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Syra Health Corp (OTC-SYRA). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Syra Health Corp (OTC-SYRA)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 6, 2026

Days to Earnings

16

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Syra Health Corp (OTC-SYRA), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Syra Health Corp (OTC-SYRA) Stock Forecast & Technical Outlook

Review Syra Health Corp (OTC-SYRA) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Syra Health Corp (OTC-SYRA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Syra Health Corp (OTC-SYRA) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Syra Health Corp (OTC-SYRA) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Syra Health Corp (OTC-SYRA) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Syra Health Corp (OTC-SYRA) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Syra Health Corp (OTC-SYRA)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Syra Health Corp (OTC-SYRA) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ • Fast Investor Answers

Syra Health Corp (OTC-SYRA) Stock FAQ

Quick answers about Syra Health Corp (OTC-SYRA) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$0.70
Estimated downside 7.6%
Valuation Rating
Overvalued
Estimated downside of 7.6%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Great
Current financial-health read

The current fair value estimate for Syra Health Corp (OTC-SYRA) is $0.70. This implies an estimated downside of 7.6% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 7.6% versus the current market price.

An analyst price target for Syra Health Corp (OTC-SYRA) is not currently available in the latest data file.

The current financial health read for Syra Health Corp (OTC-SYRA) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Syra Health Corp (OTC-SYRA) is August 6, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Syra Health Corp (OTC-SYRA) is -72.0x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Syra Health Corp is 13.178 M.

The current enterprise value listed for Syra Health Corp is 10.329 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Syra Health Corp is OTC-SYRA, and the stock is listed on OTC Markets.

Syra Health Corp (OTC-SYRA) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Syra Health Corp is 0.6%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Syra Health Corp is 39.3%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Providers & Services Stocks on OTC Markets View more

Fresenius SE & Co KGaA ADR (FSNUY) Fresenius SE & Co KGaA ADR (FSNUY)
Bangkok Dusit Medical Services PCL ADR (BDUUY) Bangkok Dusit Medical Services PCL ADR (BDUUY)
Shanghai Pharmaceuticals Holding Co Ltd ADR (SHPMY) Shanghai Pharmaceuticals Holding Co Ltd ADR (SHPMY)
Sonic Healthcare Ltd ADR (SKHHY) Sonic Healthcare Ltd ADR (SKHHY)
Ramsay Health Care Ltd ADR (RMYHY) Ramsay Health Care Ltd ADR (RMYHY)
SINOPHARM GROUP CO LTD ADR (SHTDY) SINOPHARM GROUP CO LTD ADR (SHTDY)
Bumrungrad Hospital PCL DRC (BUGDF) Bumrungrad Hospital PCL DRC (BUGDF)
Medipal Holdings Corp ADR (MAHLY) Medipal Holdings Corp ADR (MAHLY)
Extendicare Inc (EXETF) Extendicare Inc (EXETF)
Netcare Ltd ADR (NWKHY) Netcare Ltd ADR (NWKHY)
Ryman Healthcare Ltd ADR (RYHTY) Ryman Healthcare Ltd ADR (RYHTY)
Rhoen Klinikum AG ADR (RKAGY) Rhoen Klinikum AG ADR (RKAGY)
Life Healthcare Group Holdings (LTGHY) Life Healthcare Group Holdings (LTGHY)
Medical Facilities Corporation (MFCSF) Medical Facilities Corporation (MFCSF)
Healwell Al Inc (HWAIF) Healwell Al Inc (HWAIF)
Global Cord Blood Corp (CORBF) Global Cord Blood Corp (CORBF)
Kenilworth Systems C (GAMG) Kenilworth Systems C (GAMG)
Interpace Biosciences Inc (IDXG) Interpace Biosciences Inc (IDXG)
Elite Health Systems Inc (EHSI) Elite Health Systems Inc (EHSI)
Exlites Holdings International Inc (EXHI) Exlites Holdings International Inc (EXHI)
Psychemedics Corporation (PMDI) Psychemedics Corporation (PMDI)
Cardiff Lexington Corp (CDIX) Cardiff Lexington Corp (CDIX)
Pacific Health Care Organization Inc (PFHO) Pacific Health Care Organization Inc (PFHO)
BioCorRx Inc (BICX) BioCorRx Inc (BICX)